Zoll Medical is averaging an acquisition per month over the fall, announcing its 3rd deal in as many months, this time for Advanced Circulatory Systems and its non-invasive circulation assist devices.
Chelmsford, Mass.-based Zoll did not reveal financial details of the acquisition of ACS, which is based in Roseville, Minn.
In October Zoll said it agreed to acquire Impact Instrumentation, which makes respiratory care devices, for an unspecified amount. The next month Zoll announced a deal for Philips‘ (NYSE:PHG) InnerCool business and its catheter-based endovascular and surface temperature management technologies, again staying mum on the fiscal details.
Today Zoll said the deal for ACS, which makes the Intrathoracic Pressure Therapy platform, is expected to close in early 2015. Advanced Circulatory Systems will continue to operate out of Minnesota as a part of Zoll’s core products division, according to a press release.
"The acquisition of Advanced Circulatory Systems will broaden Zoll’s product offerings with additional technologies designed to improve outcomes from cardiac arrest and other critical conditions," Zoll president Jonathan Rennert said in prepared remarks. "This acquisition further demonstrates Zoll’s commitment to offering the most comprehensive portfolio of products for acute events where rapid medical intervention is needed."
"Becoming part of Zoll provides Advanced Circulatory Systems with an increased infrastructure of clinical and commercial resources that will enable our technologies to reach a greater number of clinicians and positively affect more patients’ lives," added ACD CEO Mike Black. "The acquisition gives Advanced Circulatory Systems the opportunity to become a part of a company with a long history of improving resuscitation science."
